Pharmacology & ToxicologybioRxivPreprint
Off-target mapping enhances selectivity of machine learning-predicted CK2 inhibitors
Huiyan Ying, Weikaixin Kong, Aron Schulman…·Mitro Miihkinen
The paper develops an ML-powered drug discovery pipeline to design selective CK2 inhibitors with favorable off-target profiles, achieving a 90% hit-rate.
DOI 10.1101/2025.11.12.688093